Bladder drug shows promise for dry AMD in new trial
Disease control
Not yet recruiting
This study tests if Mirabegron, a drug used for overactive bladder, can also help treat dry age-related macular degeneration (AMD). Researchers will compare Mirabegron to another bladder drug (Solifenacin) in 312 people aged 50-80 with both conditions. Participants take the drug …
Sponsor: University of Naples • Aim: Disease control
Last updated May 19, 2026 02:23 UTC